Pulmonary hypertension in adults completing tuberculosis treatment.

ABSTRACT: Pulmonary hypertension (PH) after tuberculosis (TB) is typically not included among the chronic lung diseases causing PH (group 3 PH), with few data available to support the inclusion. To determine the prevalence of PH in an adult population completing TB treatment. This single-centre, cross-sectional study only included patients with their first documented episode of TB, and who were in the second half of treatment or had recently completed treatment. PH was assessed using transthoracic echocardiography. Questionnaires were completed, and spirometry and a 6-minute walk test were performed. One hundred patients were enrolled, with a mean age of 37.1 years, of whom 58% were male and 46% HIV positive. The median time since initiation of TB treatment was 22 weeks. The mean (standard deviation

SUBMITTER: Allwood BW 

PROVIDER: S-EPMC10642409 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature